Citadel Advisors’s Incannex Healthcare IXHL Stock Holding History

Citadel Advisors’s Portfolio IXHL Stock Details IXHL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,429	Closed	-$69.6K	–	13805
2025 Q1	$69.6K	Buy	+3,429	New	+$149K	﹤0.01%	11918
2024 Q4	–	Sell	-805	Closed	-$48.1K	–	14941
2024 Q3	$48.1K	Buy	+805	New	+$49.7K	﹤0.01%	11957
2024 Q2	–	Sell	-458	Closed	-$49.3K	–	14853
2024 Q1	$49.3K	Hold	458	–	–	﹤0.01%	12182
2023 Q4	$63.7K	Buy	+458	New	+$59.7K	﹤0.01%	11516
2022 Q2	–	Sell	-100	Closed	-$110K	–	13488
2022 Q1	$110K	Buy	+100	New	+$165K	﹤0.01%	12183

Other funds holding IXHL

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

SRL

Scientech Research LLC Jersey City, New Jersey $120M AUM 73.62% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

RWM

Revisor Wealth Management Akron, Ohio $416M AUM 25.24% 1-Year Est. Return

Citadel Advisors's IXHL Position: Q2 2025 in Review

Citadel Advisors sold out of Incannex Healthcare (IXHL) in Q2 2025, closing a stake of 3,429 shares — an estimated $69.6K sold.

Citadel Advisors first reported a position in IXHL in Q1 2022 and held it in 5 quarters. The position peaked at $110K in Q1 2022. 12 funds tracked by Wall St. Rank hold IXHL as of Q2 2025.

Citadel Advisors reported no remaining Incannex Healthcare position as of Q2 2025 after selling out during the quarter.
Citadel Advisors sold 3,429 Incannex Healthcare shares in Q2 2025, an estimated $69.6K.
Citadel Advisors first reported a position in Incannex Healthcare in Q1 2022 and held it in 5 quarters.
Citadel Advisors's Incannex Healthcare position peaked at $110K in Q1 2022.
12 funds tracked by Wall St. Rank held Incannex Healthcare as of Q2 2025.

Based on Citadel Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.